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News and views
Scientific and Educational Conference 50 years
of Radioiodine Treatment in Poland: The Achieve-
ments and Prospects of Radionuclide Therapy
with the Conference Thyroid Orbitopathy,
March 24, Poznaæ, Poland
Fifty years ago, radioiodine treatment of thyroid was applied
for the first time in Poland, with the Clinic of Endocrinology
of Medical University in Poznaæ as a leading centre both then and
now. The jubilee gave an impulse to organise a Conference
50 years of radioiodine treatment in Poland: The Achievements and
Prospects of Radionuclide Therapy coupled with a Conference Thy-
roid Orbitopathy meant mainly for eye disease specialists.
The conference started with an excellent ceremonial opening
with a very interesting presentation on the history of radioiodine
treatment by Prof. Maciej Gembicki, an eminent expert on RI treat-
ment from Poznaæ. This took place in the interesting restaurant
with its own beer brewery Brovaria in the Old Market of Poznaæ.
In a session devoted to radionuclide therapy, the most inter-
esting lectures were by J. Sowiæski from Poznaæ on the RI treat-
ment of benign thyroid disorders  2005,   F. Pacini from Siena,
Italy on radioiodine therapy of thyroid carcinoma and B. Jarz„b
from the Institute of Oncology in Gliwice on actual problems on RI
treatment of thyroid carcinoma. In the next session, A. Hubalews-
ka-Dydejczyk from Cracow lectured on radioimmunotherapy,
L. Królicki and colleagues from Warsaw on radionuclide therapy
of neuroendocrine tumours and J. Kosowicz from Poznaæ on the
prospects of RN treatment of medullary carcinoma.
In the next session, very interesting lectures were given
by G. Mödder (Cologne, Germany) on the current state of radio-
synovectomy and W. Oyen (Nijmegen, The Netherlands) on ex-
perimental therapy in nuclear medicine focusing on the general
failure of radioimmunotherapy with the exception of lymphoma
treatment. A sad story. R. Junik from Bydgoszcz focused on thy-
roid orbitopathy, which was a gentle introduction to the second
part of the conference, i.e. a series of lectures devoted to thyroid
orbitopathy: its ethiopathogenesis, its treatment with indications
and contraindications, peripheral oxidative stress in hyperthyreo-
sis and thyroid ophthalmopathy and the applications of soma-
tostatin analogues in endocrine disorders.
This was an interesting experience: nuclear medicine is a small
and rather isolated discipline; therefore, any meeting with other
medical specialists is of great value to us. We have some cooper-
ation with radiologists, oncologists and cardiologists, but I never
realised the importance of the meeting point with eye disease spe-
cialists, which is thyroid ophthalmopathy.
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